Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06179589Not ApplicableCompleted

VS002A in the Treatment of Acute Watery Diarrhea in Infants and Young Children

Role: collaborator

NCT06016361Not ApplicableUnknown

Evaluation of a Novel Amino Acid Based Moisturizing Cream as Part of the Daily Standard Skincare Regimen Recommended During Radiation Therapy

Role: lead

NCT03451253Not ApplicableTerminated

Effects of an Amino Acid Mixture on Gastrointestinal Function, Inflammation and Fluid Balance: A Pilot Study in Patients With Inflammatory Bowel Disease

Role: lead

NCT04677296Not ApplicableCompleted

Efficacy and Safety of "VS002A" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children

Role: lead

NCT03722511Phase 2Completed

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Role: collaborator

NCT04073017Not ApplicableTerminated

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Role: collaborator

NCT03105362Not ApplicableTerminated

Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome

Role: collaborator

NCT03262597Not ApplicableCompleted

"Beverage Hydration Index" of Commercial Therapeutic Beverages

Role: collaborator

All 8 trials loaded